Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1955 2
1957 1
1958 1
1959 4
1961 1
1962 3
1963 9
1964 4
1965 6
1966 8
1967 7
1968 2
1969 1
1970 2
1971 3
1972 4
1973 2
1974 1
1975 3
1976 1
1977 2
1978 2
1979 7
1980 8
1981 9
1982 13
1983 11
1984 21
1985 26
1986 28
1987 28
1988 26
1989 37
1990 32
1991 39
1992 55
1993 34
1994 39
1995 67
1996 72
1997 79
1998 74
1999 98
2000 113
2001 108
2002 160
2003 165
2004 208
2005 241
2006 265
2007 265
2008 379
2009 422
2010 463
2011 496
2012 513
2013 601
2014 699
2015 784
2016 800
2017 807
2018 1022
2019 1122
2020 1337
2021 1651
2022 1792
2023 1750
2024 924

Text availability

Article attribute

Article type

Publication date

Search Results

16,128 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. Among authors: lu s. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Perioperative Nivolumab in Resectable Lung Cancer.
Cascone T, Awad MM, Spicer JD, He J, Lu S, Sepesi B, Tanaka F, Taube JM, Cornelissen R, Havel L, Karaseva N, Kuzdzal J, Petruzelka LB, Wu L, Pujol JL, Ito H, Ciuleanu TE, de Oliveira Muniz Koch L, Janssens A, Alexandru A, Bohnet S, Moiseyenko FV, Gao Y, Watanabe Y, Coronado Erdmann C, Sathyanarayana P, Meadows-Shropshire S, Blum SI, Provencio Pulla M; CheckMate 77T Investigators. Cascone T, et al. Among authors: lu s. N Engl J Med. 2024 May 16;390(19):1756-1769. doi: 10.1056/NEJMoa2311926. N Engl J Med. 2024. PMID: 38749033 Clinical Trial.
Hydrodynamics-Controlled Single-Particle Electrocatalysis.
Lu SM, Chen M, Wen H, Zhong CB, Wang HW, Yu Z, Long YT. Lu SM, et al. J Am Chem Soc. 2024 Jun 5;146(22):15053-15060. doi: 10.1021/jacs.3c14502. Epub 2024 May 22. J Am Chem Soc. 2024. PMID: 38776531
Human transferrin receptor can mediate SARS-CoV-2 infection.
Liao Z, Wang C, Tang X, Yang M, Duan Z, Liu L, Lu S, Ma L, Cheng R, Wang G, Liu H, Yang S, Xu J, Tadese DA, Mwangi J, Kamau PM, Zhang Z, Yang L, Liao G, Zhao X, Peng X, Lai R. Liao Z, et al. Among authors: lu s. Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317026121. doi: 10.1073/pnas.2317026121. Epub 2024 Feb 26. Proc Natl Acad Sci U S A. 2024. PMID: 38408250 Free PMC article.
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
Carbone DP, Ciuleanu TE, Schenker M, Cobo M, Bordenave S, Juan-Vidal O, Menezes J, Reinmuth N, Richardet E, Cheng Y, Mizutani H, Felip E, Zurawski B, Alexandru A, Paz-Ares L, Lu S, John T, Zhang X, Mahmood J, Hu N, De T, Santi I, Penrod JR, Yuan Y, Lee A, Reck M. Carbone DP, et al. Among authors: lu s. J Immunother Cancer. 2024 Feb 12;12(2):e008189. doi: 10.1136/jitc-2023-008189. J Immunother Cancer. 2024. PMID: 38346853 Free PMC article. Clinical Trial.
16,128 results
You have reached the last available page of results. Please see the User Guide for more information.